Practice guidelines for the treatment of hepatitis C: Recommendations from an AISF/SIMIT/SIMAST Expert Opinion Meeting☆
Received 14 July 2009; accepted 5 August 2009. published online 14 September 2009.
Abstract
It is increasingly clear that a tailored therapeutic approach to patients with hepatitis C virus infection is needed. Success rates in difficult to treat and low-responsive hepatitis C virus patients are not completely satisfactory, and there is the need to optimise treatment duration and intensity in patients with the highest likelihood of response. In addition, the management of special patient categories originally excluded from phase III registration trials needs to be critically re-evaluated. This article reports the recommendations for the treatment of hepatitis C virus infection on an individual basis, drafted by experts of three scientific societies.
☆ Position Paper on behalf of the following Scientific Societies: (1) Italian Association for the Study of the Liver (Associazione Italiana per lo Studio del Fegato: AISF); (2) Italian Society of Infectious, Tropical Diseases (Società Italiana per lo Studio delle Malattie Infettive e Tropicali: SIMIT); (3) Italian Society for the Study of Sexually Transmitted Diseases (Società Italiana per lo Studio delle Malattie Sessualmente Trasmissibili: SIMAST).
ABSTRACT